Epidural Analgesia for Pancreatitis (Epipan Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

148

Participants

Timeline

Start Date

June 6, 2014

Primary Completion Date

February 26, 2019

Study Completion Date

February 26, 2019

Conditions
Severe Acute Pancreatitis
Interventions
OTHER

ropivacaine and sufentanil

Thoracic epidural analgesia will be performed using ropivacaine (2 mg/ml), sufentanil (0.5 microg/ml) administered through a patient-controlled deviced (PCEA : patient-controlled epidural analgesia). PCEA parameters will be fixed as follows : continuous administration of 5 to 15 ml/h and bolus of 3 to 10 ml every 10 minutes. Iterative epidural administration of clonidine (1 mckg/kg) will be allowed to achieve analgesia goals.

OTHER

acetaminophen, nefopam, tramadol, opidoids

Conventional analgesia will include enteral and/or parental administration of usual analgesics, ranging from step 1 to step 3 drugs according to WHO classification (including acetaminophen, nefopam, tramadol, opidoids). The route, dose and frequency of analgesics administrations will be based on participating ICUs protocols.

Trial Locations (1)

63003

CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT02126332 - Epidural Analgesia for Pancreatitis (Epipan Study) | Biotech Hunter | Biotech Hunter